The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD Oncology; Roche Pharma AG
Research Funding - AstraZeneca; BeyondSpring Pharmaceuticals; Crescendo Biologics; Roche; Sectra
SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.
 
Sacha Rothschild
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck Serono (Inst)
Expert Testimony - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche Pharma AG
 
Alfred Zippelius
No Relationships to Disclose
 
Eric I Eboulet
No Relationships to Disclose
 
Spasenija Savic
No Relationships to Disclose
 
Daniel C. Betticher
No Relationships to Disclose
 
Adrienne Bettini
No Relationships to Disclose
 
Martin Frueh
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst); Takeda (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Markus Joerger
Consulting or Advisory Role - AstraZeneca (Inst); Basilea (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Basilea (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Immunophotonics (Inst); InnoMedica (Inst); Intensity Therapeutics (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Christian Britschgi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen-Cilag; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Takeda
 
Solange Peters
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Illumina (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Biocartis (Inst); Bioinvent (Inst); Blueprint Medicines; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo; Debiopharm Group (Inst); Illumina (Inst); Incyte; Janssen (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Takeda (Inst); Vaccibody (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Biodesix (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Illumina (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; MSD; Roche; Sanofi
(OPTIONAL) Uncompensated Relationships - ESMO; European Thoracic Oncology Platform (ETOP); Journal of Thoracic Oncology
 
Michael Thomas Mark
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche; Takeda
Travel, Accommodations, Expenses - Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Adrian Ochsenbein
No Relationships to Disclose
 
Wolf Dieter Janthur
Consulting or Advisory Role - MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Takeda
 
Christine Waibel
No Relationships to Disclose
 
Nicolas Mach
No Relationships to Disclose
 
Michel Gonzalez
No Relationships to Disclose
 
Patrizia Froesch
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche; Takeda
 
Gilles Godar
No Relationships to Disclose
 
Corinne Rusterholz
No Relationships to Disclose
 
Miklos Pless
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche